The Impact of Depression and/or Anxiety on Patients With Acute Coronary Syndrome After Percutaneous Coronary Interventions
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Acute Coronary Syndrome
- Sponsor
- First Affiliated Hospital Xi'an Jiaotong University
- Enrollment
- 5000
- Locations
- 1
- Primary Endpoint
- Major Adverse Cardiovascular Events
- Last Updated
- 7 years ago
Overview
Brief Summary
The purpose of this study is to evaluate how depression and/or anxiety could effect the prognosis of the patients post-ACS after PCI.
Detailed Description
This trial is a prospective, multi-centric, real-world clinical study. About 5,000 patients with ACS post-PCI will be recruited according to the resource available of each participating center to represent real-world setting. Patients enrolled in the project will accept two-years' follow-up and will be assessed on mortality, cardiovascular events, and severity of depressive or anxiety symptoms using self-rating scales continuously during the trial, in which their treatment for anxiety or depression will also be documented.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Major Adverse Cardiovascular Events
Time Frame: From date of first visit until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 24 months
death, myocardial infarction, stroke, angina pectoris, revascularization.
Secondary Outcomes
- Depression self-rating scales(From date of first visit until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 24 months)
- Anxiety self-rating scales(From date of first visit until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 24 months)